Bright Minds Biosciences (DRUG) Enterprise Value: 2019-2021
- Bright Minds Biosciences' Enterprise Value was N/A to -$22.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was -$44.3 million, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2024, which is 13.46% down from last year.
- Latest data reveals that Bright Minds Biosciences reported Enterprise Value of -$22.0 million as of Q2 2021, which was down 9.44% from -$20.1 million recorded in Q1 2021.
- Over the past 5 years, Bright Minds Biosciences' Enterprise Value peaked at -$60,603 during Q3 2019, and registered a low of -$22.0 million during Q2 2021.
- Its 3-year average for Enterprise Value is -$8.9 million, with a median of -$1.6 million in 2020.
- Data for Bright Minds Biosciences' Enterprise Value shows a maximum YoY slumped of 890.51% (in 2020) over the last 5 years.
- Over the past 3 years, Bright Minds Biosciences' Enterprise Value (Quarterly) stood at -$60,603 in 2019, then plummeted by 890.51% to -$1.6 million in 2020, then reached -$22.0 million in 2021.
- Its Enterprise Value was -$22.0 million in Q2 2021, compared to -$20.1 million in Q1 2021 and -$1.6 million in Q4 2020.
